Objectives Elevated blood cholesterol (hypercholesterolemia) is a significant cause of cardiovascular disease. We aimed to estimate national and zonal prevalence of …
EI Okaka, BO Eiya - Afr J Med Health Sci 2013; 12 (2): 82, 2013 - researchgate.net
Background: Cardiovascular disease is a leading cause of morbidity and mortality world- wide. Dyslipidemia is a major risk factor for cardiovascular diseases, which can be identified …
Background: The burden of cardiovascular diseases in developing countries such as Nigeria is worsened by the increasing prevalence of cardiovascular risk factors. This study is …
OO Oresegun, OS Ogah, OB Familoni… - International Journal of …, 2020 - academia.edu
Background: Hypertension and dyslipidaemia are two major modifiable cardiovascular risk factors with their coexistence having more than an additive effect on endothelial function …
Background: Dyslipidaemia is a general term used to describe high levels of LDL-C, TGs or low levels of HDL. They are major to atherosclerosis and its related conditions such as …
Purpose: To investigate prevalence, describe pattern and management of dyslipidaemia in hypertensive patients. Methods: A descriptive cross-sectional study was carried out on …
A Emmanuella, C Eze - Journal of Advances in …, 2018 - publications.article4sub.com
Introduction: Cardiovascular diseases (CVDs) are a leading cause of death worldwide. Atherogenic Index of Plasma (AIP)(log10 triglyceride TG/high density lipoprotein cholesterol …
Recently the EAS came out with guidelines in the evaluation and management of symptoms associated with muscle adverse effects of statins, the most common adverse event with their …
Background: Hypertension is a major health problem worldwide. Its role, and other well- known coronary risk factors, especially dyslipidemia, in atherogenesis have informed …